Table 3: Number and percentage of patients with an ACR20 response, together with the number of patients with a 20% improvement for each core variable. 20 after each variable indicates 20% improvement.

VariablePlacebo ( )Active ( )Placebo-active value
Number%Number%Difference %95% CI

ACR2000217 −17−38 to 4.5
Completed81007584214 to 70.06
HAQ2000217−17−38 to 4.5
VAS Assess.2056343329−14 to 72.4
Pat. Pain20113325−13−46 to 21.6
Pat. Dis. Assess.20113217−4−35 to 271.0
CRP203384334−39 to 471.0
ESR20563185417 to 91.02
Swollen joint204506500−45 to 45 1.0
Tender joint2067565025−16 to 66.4